Hospital Parc Tauli

Sabadell, Barcelona 08208

0 studies enrolling now · 2 studies all time

What they study most

Follicular Lymphoma, Renal Cell Carcinoma (RCC)

Studies at this site

• Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) — Completed
• A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed